Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,585 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practice.
Fong CH, Meti N, Kruser T, Weiss J, Liu ZA, Takami H, Narita Y, de Moraes FY, Dasgupta A, Ong CK, Yang JCH, Lee JH, Kosyak N, Pavlakis N, Kongkham P, Doherty M, Leighl NB, Shultz DB. Fong CH, et al. Among authors: weiss j. J Thorac Dis. 2023 Aug 31;15(8):4367-4378. doi: 10.21037/jtd-22-697. Epub 2023 Aug 14. J Thorac Dis. 2023. PMID: 37691657 Free PMC article.
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models.
Martins-Filho SN, Weiss J, Pham NA, Li Q, Cabanero M, Fares A, Stewart EL, Shi R, Patel D, Pal P, McConnell J, Bradbury PA, Sacher AG, Leighl NB, Grindlay A, Allison F, Li M, Yasufuku K, Shepherd FA, Moghal N, Tsao MS, Liu G. Martins-Filho SN, et al. Among authors: weiss j. Lung Cancer. 2020 Jul;145:144-151. doi: 10.1016/j.lungcan.2020.03.022. Epub 2020 May 11. Lung Cancer. 2020. PMID: 32447118
BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer.
Shi R, Filho SNM, Li M, Fares A, Weiss J, Pham NA, Ludkovski O, Raghavan V, Li Q, Ravi D, Cabanero M, Moghal N, Leighl NB, Bradbury P, Sacher A, Shepherd FA, Yasufuku K, Tsao MS, Liu G. Shi R, et al. Among authors: weiss j. Lung Cancer. 2020 Aug;146:78-85. doi: 10.1016/j.lungcan.2020.05.018. Epub 2020 May 21. Lung Cancer. 2020. PMID: 32521388
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.
Chan SWS, Smith E, Aggarwal R, Balaratnam K, Chen R, Hueniken K, Fazelzad R, Weiss J, Jiang S, Shepherd FA, Bradbury PA, Sacher AG, Leighl NB, Xu W, Brown MC, Eng L, Liu G. Chan SWS, et al. Among authors: weiss j. Clin Lung Cancer. 2021 Sep;22(5):390-407. doi: 10.1016/j.cllc.2021.01.002. Epub 2021 Jan 10. Clin Lung Cancer. 2021. PMID: 33582072
Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer.
Moraes FY, Mansouri A, Dasgupta A, Ramotar M, Kosyak N, Weiss J, Laperriere N, Millar BA, Berlin A, Conrad T, van Prooijen M, Heaton R, Coolens C, Winter J, Bernstein M, Zadeh G, Kongkham P, Doherty M, Shultz DB. Moraes FY, et al. Among authors: weiss j. Lung Cancer. 2021 May;155:34-39. doi: 10.1016/j.lungcan.2021.02.036. Epub 2021 Mar 2. Lung Cancer. 2021. PMID: 33721614
A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis.
Yan M, Sigurdson S, Greifer N, Kennedy TAC, Toh TS, Lindsay PE, Weiss J, Hueniken K, Yeung C, Sugumar V, Sun A, Bezjak A, Cho BCJ, Raman S, Hope AJ, Giuliani ME, Stuart EA, Owen T, Ashworth A, Robinson A, de Moraes FY, Liu G, Lok BH. Yan M, et al. Among authors: weiss j. Cancers (Basel). 2021 Jun 9;13(12):2895. doi: 10.3390/cancers13122895. Cancers (Basel). 2021. PMID: 34207857 Free PMC article.
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy.
Lau SCM, Ryan M, Weiss J, Fares AF, Garcia M, Schmid S, Kuang S, Kelly D, Tsao MS, Bradbury PA, Cho BCJ, Sun A, Raman S, Hope A, Giuliani M, Lok BH, Bezjak A, Liu G, Leighl NB, Shepherd FA, Sacher AG. Lau SCM, et al. Among authors: weiss j. JTO Clin Res Rep. 2021 Nov 2;2(12):100251. doi: 10.1016/j.jtocrr.2021.100251. eCollection 2021 Dec. JTO Clin Res Rep. 2021. PMID: 34917991 Free PMC article.
Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value?
Yang K, Landry AP, Aljoghaiman M, Gutierrez E, Millesi M, Leite M, Kalyvas A, Jablonska PA, Vialet J, Weiss J, Millar BA, Conrad T, Laperriere N, Bernstein M, Zadeh G, Shultz D, Kongkham PN. Yang K, et al. Among authors: weiss j. J Neurooncol. 2022 Mar;157(1):157-163. doi: 10.1007/s11060-022-03957-1. Epub 2022 Jan 29. J Neurooncol. 2022. PMID: 35092549
Multiplicity does not significantly affect outcomes in brain metastasis patients treated with surgery.
Yang K, Gutiérrez-Valencia E, Landry AP, Kalyvas A, Millesi M, Leite M, Jablonska PA, Weiss J, Millar BA, Conrad T, Laperriere N, Bernstein M, Zadeh G, Shultz D, Kongkham PN. Yang K, et al. Among authors: weiss j. Neurooncol Adv. 2022 Mar 22;4(1):vdac022. doi: 10.1093/noajnl/vdac022. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35386569 Free PMC article.
5,585 results